Envveno Medical Corp (NVNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,849 | -19,472 | -15,736 | -11,197 | -4,503 |
| Depreciation Amortization | 124 | 489 | 372 | 252 | 122 |
| Accounts payable and accrued liabilities | 15 | 1 | 383 | 907 | -440 |
| Other Working Capital | -27 | -396 | 144 | 844 | -482 |
| Other Operating Activity | 499 | 3,810 | 2,712 | 1,461 | 1,285 |
| Operating Cash Flow | $-3,238 | $-15,568 | $-12,125 | $-7,733 | $-4,018 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -5 | -5 | -5 | N/A |
| Purchase Of Investment | -22,242 | -46,018 | -26,702 | -16,807 | -8,874 |
| Sale Of Investment | 25,012 | 61,879 | 38,381 | 24,835 | 14,075 |
| Investing Cash Flow | $2,770 | $15,856 | $11,674 | $8,023 | $5,201 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 1,023 | 241 | 0 | N/A |
| Financing Cash Flow | $N/A | $1,023 | $241 | $N/A | $N/A |
| Beginning Cash Position | 3,065 | 1,754 | 1,754 | 1,754 | 1,754 |
| End Cash Position | 2,597 | 3,065 | 1,544 | 2,044 | 2,937 |
| Net Cash Flow | $-468 | $1,311 | $-210 | $290 | $1,183 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,238 | -15,568 | -12,125 | -7,733 | -4,018 |
| Capital Expenditure | N/A | -5 | -5 | -5 | N/A |
| Free Cash Flow | -3,238 | -15,573 | -12,130 | -7,738 | -4,018 |